- Home
- UPLD vs LPTX Comparison
UPLD vs LPTX Comparison
Compare UPLD & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- LPTX
- Stock Information
- Founded
- UPLD 2010
- LPTX 2011
- Country
- UPLD United States
- LPTX United States
- Employees
- UPLD N/A
- LPTX N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UPLD Technology
- LPTX Health Care
- Exchange
- UPLD Nasdaq
- LPTX Nasdaq
- Market Cap
- UPLD 115.3M
- LPTX 119.6M
- IPO Year
- UPLD 2014
- LPTX N/A
- Fundamental
- Price
- UPLD $2.75
- LPTX $0.40
- Analyst Decision
- UPLD Hold
- LPTX Buy
- Analyst Count
- UPLD 1
- LPTX 2
- Target Price
- UPLD N/A
- LPTX $8.00
- AVG Volume (30 Days)
- UPLD 89.7K
- LPTX 380.7K
- Earning Date
- UPLD 05-12-2025
- LPTX 05-13-2025
- Dividend Yield
- UPLD N/A
- LPTX N/A
- EPS Growth
- UPLD N/A
- LPTX N/A
- EPS
- UPLD N/A
- LPTX N/A
- Revenue
- UPLD $267,713,000.00
- LPTX N/A
- Revenue This Year
- UPLD N/A
- LPTX N/A
- Revenue Next Year
- UPLD N/A
- LPTX N/A
- P/E Ratio
- UPLD N/A
- LPTX N/A
- Revenue Growth
- UPLD N/A
- LPTX N/A
- 52 Week Low
- UPLD $1.79
- LPTX $0.22
- 52 Week High
- UPLD $5.64
- LPTX $4.79
- Technical
- Relative Strength Index (RSI)
- UPLD 58.59
- LPTX 52.96
- Support Level
- UPLD $2.27
- LPTX $0.33
- Resistance Level
- UPLD $2.98
- LPTX $0.38
- Average True Range (ATR)
- UPLD 0.19
- LPTX 0.03
- MACD
- UPLD 0.08
- LPTX 0.00
- Stochastic Oscillator
- UPLD 70.13
- LPTX 72.73
About UPLD Upland Software Inc.
Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .